Mutate and Conjugate: A Method to Enable Rapid In-Cell Target Validation.
Mutate and Conjugate: A Method to Enable Rapid In-Cell Target Validation.
复制标题
DOI:
10.1021/acschembio.3c00437
复制
发表时间:
2023-11-17
影响因子:
4
通讯作者:
Conway, Stuart J.
中科院分区:
文献类型:
--
作者:
Thomas, Adam M.;Serafini, Marta;Grant, Emma K.;Coombs, Edward A. J.;Bluck, Joseph P.;Schiedel, Matthias;Mcdonough, Michael A.;Reynolds, Jessica K.;Lee, Bernadette;Platt, Michael;Sharlandjieva, Vassilena;Biggin, Philip C.;Duarte, Fernanda;Milne, Thomas A.;Bush, Jacob T.;Conway, Stuart J.
Target validation remains a challenge in drug discovery, which leads to a high attrition rate in the drug discovery process, particularly in Phase II clinical trials. Consequently, new approaches to enhance target validation are valuable tools to improve the drug discovery process. Here, we report the combination of site-directed mutagenesis and electrophilic fragments to enable the rapid identification of small molecules that selectively inhibit the mutant protein. Using the bromodomain-containing protein BRD4 as an example, we employed a structure-based approach to identify the L94C mutation in the first bromodomain of BRD4 [BRD4(1)] as having a minimal effect on BRD4(1) function. We then screened a focused, KAc mimic-containing fragment set and a diverse fragment library against the mutant and wild-type proteins and identified a series of fragments that showed high selectivity for the mutant protein. These compounds were elaborated to include an alkyne click tag to enable the attachment of a fluorescent dye. These clickable compounds were then assessed in HEK293T cells, transiently expressing BRD4(1)WT or BRD4(1)L94C, to determine their selectivity for BRD4(1)L94C over other possible cellular targets. One compound was identified that shows very high selectivity for BRD4(1)L94C over all other proteins. This work provides a proof-of-concept that the combination of site-directed mutagenesis and electrophilic fragments, in a mutate and conjugate approach, can enable rapid identification of small molecule inhibitors for an appropriately mutated protein of interest. This technology can be used to assess the cellular phenotype of inhibiting the protein of interest, and the electrophilic ligand provides a starting point for noncovalent ligand development.
登录
查看更多内容
影响因子:
14.8
作者:
Arrowsmith CH;Audia JE;Austin C;Baell J;Bennett J;Blagg J;Bountra C;Brennan PE;Brown PJ;Bunnage ME;Buser-Doepner C;Campbell RM;Carter AJ;Cohen P;Copeland RA;Cravatt B;Dahlin JL;Dhanak D;Edwards AM;Frederiksen M;Frye SV;Gray N;Grimshaw CE;Hepworth D;Howe T;Huber KV;Jin J;Knapp S;Kotz JD;Kruger RG;Lowe D;Mader MM;Marsden B;Mueller-Fahrnow A;Müller S;O'Hagan RC;Overington JP;Owen DR;Rosenberg SH;Roth B;Ross R;Schapira M;Schreiber SL;Shoichet B;Sundström M;Superti-Furga G;Taunton J;Toledo-Sherman L;Walpole C;Walters MA;Willson TM;Workman P;Young RN;Zuercher WJ
通讯作者:
Zuercher WJ
DOI:
10.1126/science.1249830
发表时间:
2014-10-31
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Baud MGJ;Lin-Shiao E;Cardote T;Tallant C;Pschibul A;Chan KH;Zengerle M;Garcia JR;Kwan TT;Ferguson FM;Ciulli A
通讯作者:
Ciulli A
DOI:
10.1126/science.aaz8455
发表时间:
2020-04-24
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Gilan O;Rioja I;Knezevic K;Bell MJ;Yeung MM;Harker NR;Lam EYN;Chung CW;Bamborough P;Petretich M;Urh M;Atkinson SJ;Bassil AK;Roberts EJ;Vassiliadis D;Burr ML;Preston AGS;Wellaway C;Werner T;Gray JR;Michon AM;Gobbetti T;Kumar V;Soden PE;Haynes A;Vappiani J;Tough DF;Taylor S;Dawson SJ;Bantscheff M;Lindon M;Drewes G;Demont EH;Daniels DL;Grandi P;Prinjha RK;Dawson MA
通讯作者:
Dawson MA
影响因子:
64.8
作者:
通讯作者:
--
影响因子:
7.3
作者:
Hewings, David S.;Fedorov, Oleg;Filippakopoulos, Panagis;Martin, Sarah;Picaud, Sarah;Tumber, Anthony;Wells, Christopher;Olcina, Monica M.;Freeman, Katherine;Gill, Andrew;Ritchie, Alison J.;Sheppard, David W.;Russell, Angela J.;Hammond, Ester M.;Knapp, Stefan;Brennan, Paul E.;Conway, Stuart J.
通讯作者:
Conway, Stuart J.